EPISODE · Oct 28, 2025 · 1H 9M
Ep188: Art Krieg on Innate Immune System Activators for Cancer
from The Long Run with Luke Timmerman · host Timmerman Report
Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.
What this episode covers
Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.
NOW PLAYING
Ep188: Art Krieg on Innate Immune System Activators for Cancer
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m